356 related articles for article (PubMed ID: 12697942)
1. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
[TBL] [Abstract][Full Text] [Related]
2. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Trends, and Survival of Children With Embryonal Tumors.
Tulla M; Berthold F; Graf N; Rutkowski S; von Schweinitz D; Spix C; Kaatsch P
Pediatrics; 2015 Sep; 136(3):e623-32. PubMed ID: 26304823
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in embryonal tumours of the central nervous system.
Sarkar C; Deb P; Sharma MC
Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
[TBL] [Abstract][Full Text] [Related]
5. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
Story E; Johnston DL; Bartels U; Carret AS; Crooks B; Eisenstat DD; Fryer C; Lafay-Cousin L; Larouche V; Wilson B; Zelcer S; Silva M; Brossard J; Bouffet E; Keene DL
J Neurooncol; 2017 Jul; 133(3):581-587. PubMed ID: 28508928
[TBL] [Abstract][Full Text] [Related]
6. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of CNS embryonal tumors.
Momota H; Holland EC
Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
[TBL] [Abstract][Full Text] [Related]
8. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
9. [Germ cell and embryonal tumors].
Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
13. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.
Rosenberg T; Cooney T
Pediatr Neurosurg; 2023; 58(5):299-306. PubMed ID: 37245504
[TBL] [Abstract][Full Text] [Related]
14. Genomic Molecular Classification of CNS Malignancies.
Spino M; Snuderl M
Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
[TBL] [Abstract][Full Text] [Related]
15. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Gajjar A; Mahajan A; Abdelbaki M; Anderson C; Antony R; Bale T; Bindra R; Bowers DC; Cohen K; Cole B; Dorris K; Ermoian R; Franson A; Helgager J; Landi D; Lin C; Metrock L; Nanda R; Palmer J; Partap S; Plant A; Pruthi S; Reynolds R; Ruggieri P; Stearns D; Storm P; Wang A; Warren K; Whipple N; Zaky W; McMillian NR; Pluchino LA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1339-1362. PubMed ID: 36509072
[TBL] [Abstract][Full Text] [Related]
18. Aggressive infantile embryonal tumors.
MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
20. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
